Table 3.

Prevalence of antimicrobial resistance in healthcare-onset/associated E. coli bacteriuria episodes compared to those that are community-onset, 2014–2020

	RR (95% CI)
	NIT	T/S	CIP	ESBL	Any AMR	MDR
Community onset (reference)
Healthcare onset/associated	1.98 (1.40, 2.79)	1.23 (1.14, 1.32)	1.96 (1.80, 2.13)	3.00 (2.65, 3.39)	1.17 (1.13, 1.22)	1.86 (1.69, 2.05)

Data from a public healthcare system including inpatient and outpatient services and a skilled nursing facility; RR: risk ratio, NIT: nitrofurantoin, T/S: trimethoprim/sulfamethoxazole, CIP: ciprofloxacin, ESBL: extended-spectrum beta-lactamase, AMR: antimicrobial resistance, MDR: multidrug resistance